Malin Lemurell

Expansive discovery of chemically diverse structured macrocyclic oligoamides

Accurate de novo design of heterochiral protein–protein interactions

Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective

Targeted Protein Degradation: from Chemical Biology to Drug Discovery

Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor

In-solution enrichment identifies peptide inhibitors of protein–protein interactions

The road to fully programmable protein catalysis

Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites

PROTAC targeted protein degraders: the past is prologue

Activation of H₂O₂ by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation

Macrocycles in Drug Discovery─Learning from the Past for the Future

Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations

Adapting free energy perturbation simulations for large macrocyclic ligands: how to dissect contributions from direct binding and free ligand flexibility

Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges

Asymmetric Counteranion‐Directed Iron Catalysis: A Highly Enantioselective Sulfoxidation

Extending the application of biocatalysis to meet the challenges of drug development

ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor

Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia

Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs

Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?

Enantioselective Synthesis of Sulfoxides: 2000−2009

Conformational Strain of Macrocyclic Peptides in Ligand–Receptor Complexes Based on Advanced Refinement of Bound-State Conformers

Enzyme-catalysed oxygenation and deoxygenation routes to chiral thiosulfinates

Discovery of AZD6642, an Inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the Treatment of Inflammatory Diseases

Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments

New Modalities for Challenging Targets in Drug Discovery

Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung